Phase 2: Idarubicin Nanoparticle Formulation Development and Preclined Evaluation

  • Mumper, Russell (PI)
  • Leggas, Markos (CoI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/076/30/07